Depot-Based Delivery Systems for Pro-Angiogenic Peptides: A Review

Insufficient vascularization currently limits the size and complexity for all tissue engineering approaches. Additionally, increasing or re-initiating blood flow is the first step toward restoration of ischemic tissue homeostasis. However, no FDA-approved pro-angiogenic treatments exist, despite the...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Hove, Amy H., Benoit, Danielle S. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504170/
https://www.ncbi.nlm.nih.gov/pubmed/26236708
http://dx.doi.org/10.3389/fbioe.2015.00102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504170/
https://www.ncbi.nlm.nih.gov/pubmed/26236708
http://dx.doi.org/10.3389/fbioe.2015.00102

Ejemplares similares